T0	Participants 90 124	advanced nasopharyngeal carcinoma.
T1	Participants 273 318	patients with nasopharyngeal carcinoma (NPC).
T2	Participants 410 511	42 patients with NPC was compared with a control group of 40 patients with NPC treated with RT alone.
T3	Participants 1315 1332	patients with NPC
T4	Participants 1705 1722	patients with NPC
T5	Participants 1862 1880	patients with NPC.